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The Xenopus origin recognition complex is essential
for chromosomal DNA replication in cell-free extracts.
We have immunopurified the Xenopus origin recogni-
tion complex with anti-Xorc2 antibodies and analyzed
its composition and properties. Xorc2 (p63) is specifi-
cally associated with Xorc1 (p115) and up to four addi-
tional polypeptides (p81, p78, p45, and p40). The cDNA
encoding p81 is highly homologous to various expressed
sequence tags from humans and mice encoding a pro-
tein of previously unknown function. Immunodepletion
of p81 from Xenopus egg extracts, which also results in
the removal of Xorc2, completely abolishes chromo-
somal DNA replication. Thus, p81 appears to play a cru-
cial role at S phase in higher eukaryotes.
The regulation of DNA replication involves the coordinated
action of various proteins that associate with chromosomes in a
specific manner (reviewed in Refs. 1 and 2). In the budding
yeast Saccharomyces cerevisiae, the origin recognition complex
(ORC)1 binds to origins of replication and is essential for the
onset of DNA replication. ORC is bound to budding yeast ori-
gins throughout the cell cycle, implying that other factors dic-
tate when initiation of replication will occur (3–8). Before S
phase, ORC resides in a pre-replicative complex that contains
Cdc6 and other key replication factors such as the Mcms (mini-
chromosome maintenance proteins) (5–10). Upon the firing of
origins, the footprint of ORC on the DNA switches to a post-
replicative form. Because this pattern is similar to that which
is observed for purified ORC bound to DNA, the post-replica-
tive complex may consist only of ORC. The mechanisms that
govern the switch from the pre-replicative complex to the post-
replicative complex remain to be established fully. However,
the cyclin-dependent kinases, including Clb-associated Cdc28
in budding yeast and Cdk2-cyclin E in higher eukaryotes such
as Xenopus, are likely to play a key role (11, 12). Additionally,
recent evidence suggests that the conserved kinase Cdc7 reg-
ulates the Mcms at S phase (8, 13, 14).
ORC components have been identified in a wide range of
eukaryotes, including budding and fission yeast, flies, frogs,
and humans, suggesting that the mechanism of initiation of
eukaryotic DNA replication might be universally conserved
(15–20). Despite the conservation of several ORC subunits from
yeast to metazoans, the identification of replicator sequences in
higher eukaryotes has proven elusive. The functional reconsti-
tution of a metazoan ORC might provide an avenue for the
identification of replication origins in more complex eu-
karyotes. Furthermore, this reconstituted complex would facil-
itate the elucidation of mechanisms governing initiation of
DNA replication in higher eukaryotic chromosomes.
Xenopus egg extracts have proven highly valuable for the
study of cell cycle events such as DNA replication in vitro.
Previous studies have established an essential role for two
Xenopus homologs of budding yeast ORC subunits (Xorc1 and
Xorc2) in the initiation of DNA replication (18, 20). In this
report , we present a further characterization of Xenopus ORC
(XORC). In particular, we have focused on an 81-kDa protein
(p81) that is tightly associated with a complex containing
Xorc2. cDNA cloning studies indicate that p81 is highly homol-
ogous to putative human and mouse proteins of previously
unknown function. Although p81 does not possess an obvious
homolog in S. cerevisiae, it displays some limited sequence
identity to the budding yeast Orc3 protein. Removal of p81
from Xenopus egg extracts completely abolishes the capacity of
these extracts to carry out chromosomal DNA replication.
Hence, p81 appears to be an essential replication factor in
higher eukaryotes.
EXPERIMENTAL PROCEDURES
Xenopus Extracts—Cytostatic factor-arrested egg extracts were pre-
pared from unactivated Xenopus eggs as described by Murray (21).
Cytostatic factor-arrested extracts were induced to enter the interphase
state by the addition of 0.4 mM CaCl2. Interphase extracts were also
supplemented with 100 mg/ml cycloheximide to prevent the entry into
mitosis. S phase cytosol was prepared according to the method of
Smythe and Newport (22). Extracts from developmentally staged Xe-
nopus embryos were prepared as described (23).
Immunopurification and Isolation of Xorc2-associated Proteins—To
isolate Xorc2-associated proteins, interphase egg extracts (3–5 ml) were
treated with anti-Xorc2 antibodies (18) covalently coupled to the Affi-
Prep protein A support (Bio-Rad) by the method of Schneider et al. (24).
Typically, 100 mg of anti-Xorc2 antibodies was coupled to 50 ml of
protein A beads and incubated with egg extract for 1 h at 4 °C. After
incubation, the beads were collected and extensively washed three
times with extract buffer (80 mM b-glycerophosphate, 20 mM EGTA, and
15 mM MgCl2, pH 7.3) containing 1% Nonidet P-40, three times with
extract buffer containing 1% Nonidet P-40 and 0.4 M sodium chloride,
three times with extract buffer alone, and once with HEPES-buffered
saline (10 mM HEPES-KOH and 150 mM NaCl, pH 7.4). Finally, the
beads were resuspended in Tris-buffered saline (10 mM Tris-HCl and
150 mM NaCl, pH 7.4) containing 0.1% SDS and boiled for 5 min. A
small aliquot of the eluted fraction was subjected to SDS gel electro-
phoresis and either silver-stained or processed for immunoblotting with
either anti-Xorc1 (20) or anti-Xorc2 antibodies. The eluted proteins
from several preparations were combined and concentrated with a
Filtron microconcentrator. The concentrated eluate was treated with 15
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted
to the GenBankTM/EBI Data Bank with accession number(s)
AF045607.
‡ Supported by postdoctoral fellowships from the American Cancer
Society and the E. S. Gosney Fund.
§ Supported by the Howard Hughes Medical Institute. To whom
correspondence should be addressed. Tel.: 626-395-8433; Fax: 626-449-
0679; E-mail: dunphy@cco.caltech.edu.
1 The abbreviations used are: ORC, origin recognition complex;
XORC, Xenopus origin recognition complex; kb, kilobase pair; PCR,
polymerase chain reaction; GST, glutathione S-transferase; CHAPS,
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 273, No. 38, Issue of September 18, pp. 24891–24897, 1998
© 1998 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 24891
mM dithiothreitol and 50 mM iodoacetamide prior to electrophoresis on
a preparative 8% polyacrylamide gel. Xorc2-associated bands were vi-
sualized by staining for 20 min with 0.2% Coomassie Brilliant Blue
(dissolved in 20% methanol and 0.5% acetic acid) and destaining for 1 h
with 30% methanol. One band, termed p81 due its apparent molecular
mass of 81 kDa, was excised from the gel and processed for peptide
sequencing by the California Institute of Technology Protein/Peptide
Micro Analytical Laboratory. Amino acid sequences were obtained from
three tryptic fragments as follows: peptide A, TSLTVADYFNEGLR;
peptide B, XEFVFKPSAK; and peptide C, VALHTALNNPASYLK. X
denotes an unreadable amino acid.
32P Labeling of Xenopus Extracts—32P-Labeled orthophosphate (500
mCi/ml) was added to cytostatic factor-arrested extracts containing 100
mg/ml cycloheximide and incubated for up to 1 h at 23 °C to allow
incorporation into endogenous ATP. The extract was split in half. One
aliquot was activated with calcium, and the other was kept arrested at
metaphase. After an additional 30-min incubation, the extracts were
immunoprecipitated with anti-Xorc2 antibodies bound to protein A
beads. Immunoprecipitated proteins were washed as described above,
except that the first three washes also contained 1 mM microcystin,
resuspended in SDS gel sample buffer, and electrophoresed on 10% SDS
gels. Radiolabeled bands were visualized by autoradiography or trans-
ferred to polyvinylidene difluoride membranes and processed for phos-
phoamino acid analysis (25).
Cloning of the cDNA Encoding p81—Six degenerate oligonucleotides
were designed from the sequences of the p81 tryptic peptides. One
combination of primers was found to amplify an internal 1.6-kb frag-
ment of Xenopus p81 in a polymerase chain reaction (PCR). These two
primers are as follows: B-forward, 59-ACIGTIGCIGA(T/C)TA(T/C)TT(T/
C)AA(T/C)GA(A/G)GG-39; and C-reverse, 59-(G/C)(T/A)IGCIGG(G/
A)TT(G/A)TTIA(G/A)IGCIGT(G/A)TG-39. The PCR conditions of Muel-
ler et al. (26) were used. After electrophoresis of the PCR products, the
1.6-kb band was reamplified and subcloned into the pCRII cloning
vector (Invitrogen). This fragment was radiolabeled by the random
primer method using a kit from Life Technologies, Inc. and used to
screen 106 clones from a Xenopus oocyte cDNA library (18, 26). Eighteen
cDNA clones were isolated; the longest one (a 2.3-kb ApaI-XhoI frag-
ment) was sequenced on both strands using an automated DNA se-
quencer. By conceptual translation, this cDNA was found to contain an
81-kDa open reading frame. Although the presumed initiation codon is
not preceded by an in-frame termination codon, it does reside in a good
Kozak consensus sequence (27). Furthermore, the apparent molecular
mass of recombinant histidine-tagged p81 (84 kDa) is 3 kDa larger than
that of endogenous p81 in Xenopus egg extracts detected with anti-p81
antibodies. Thus, the 2.3-kb cDNA appears to contain the full-length
coding sequence of p81.
Production of Recombinant p81 and anti-p81 Antibodies—We ex-
pressed Xenopus p81 using the BAC-to-BAC baculovirus expression
system (Life Technologies, Inc.). The full-length coding sequence of p81
was subcloned into pFastBacHTa via a triple-ligation strategy. An NcoI
restriction site was engineered at the initiation codon by PCR with Pfu
polymerase. A 1.3-kb NcoI-XbaI fragment and a 1.0-kb XbaI-XhoI frag-
ment, which together contained the entire coding sequence, were li-
gated to pFastBacHTa that had been digested with NcoI and XbaI. p81
protein was expressed in Sf9 insect cells as described previously (26,
28). The protein was isolated from the inclusion body fraction of solu-
bilized Sf9 cells in essentially pure form and used to immunize rabbits
for polyclonal antibody production. Antibodies directed against p81
were affinity-purified essentially as described (10), except that p81 was
coupled to CNBr-Sepharose beads after it had been solubilized in 8 M
urea.
Other Methods—GST-p21N (29) was prepared as described for p21
(11). Immunodepletions of Xenopus interphase extracts with anti-p81
antibodies were performed as described (18), except that three rounds of
depletion were performed. For each round, 30 mg of anti-p81 antibodies
was used per 50 ml of egg extract. For the rescue of p81-depleted
extracts, demembranated sperm chromatin was incubated in S phase
cytosol (22) for 5 min and then diluted with 2 volumes of extract buffer
(10 mM HEPES-KOH, 0.1 M KCl, 0.1 mM CaCl2, 1.0 mM MgCl2, and 50
mM sucrose, pH 7.7) supplemented with 1 mg/ml bovine serum albumin
and 7 mM ATP. The “loaded” chromatin was then centrifuged in a
Beckman Microfuge E containing a horizontal rotor for 1 min at 4 °C.
Either p81-depleted or mock-depleted extracts were added to the pellet
containing the loaded chromatin. DNA replication assays were per-
formed as described (18). Immunoblotting with anti-Xorc2 antibodies
was performed as described (18). Immunoblotting with anti-p81 anti-
bodies was performed in BLOTTO (26), and proteins were detected with
the ECL system (Amersham Pharmacia Biotech).
RESULTS
Identification of Xorc2-associated Proteins—We previously
demonstrated that Xorc2 is essential for chromosomal DNA
replication in Xenopus extracts (18). Xorc2 is found in a large
multiprotein assembly, suggesting that it resides in XORC (18,
20, 30). By immunoprecipitation with anti-Xorc2 antibodies, we
observed the presence of several Xorc2-associated proteins
(Fig. 1A, lane 1). Immunoblotting of anti-Xorc2 immunoprecipi-
tates confirmed that Xorc1 and Xorc2 reside in the same mul-
tiprotein complex (Fig. 1, B and C, lanes 1) (20, 30). Moreover,
it was clear from silver staining of the immunoprecipitates that
at least four or five proteins tightly associated with Xorc2 (63
kDa) even after stringent washes in 0.5 M NaCl and 0.1%
CHAPS (Fig. 1A; see “Experimental Procedures”). In addition
to Xorc1 (115 kDa), there were polypeptides with apparent
molecular masses of 81, 78, 46, and 40 kDa. The 78-kDa band
also appeared in immunoprecipitates with control antibodies
(albeit at lower levels) and thus may represent a nonspecific
binding protein. Typically, the 81-kDa band silver-stained
more intensely than Xorc2 in these preparations, suggesting
that it might be more abundant than Xorc2 in the complex.
However, when large-scale anti-Xorc2 immunoprecipitates
were stained with Coomassie Blue, the amounts of p81 and
Xorc2 were found to be comparable (data not shown), suggest-
ing that p81 may stain anomalously well with silver.
Xorc1 and Xorc2 Are Phosphorylated Differentially through-
out the Cell Cycle—To characterize the Xorc2-containing com-
plex in greater detail, we examined the phosphorylation of its
FIG. 1. Characterization of Xorc2-
associated proteins in interphase ex-
tracts. A, immunoprecipitates prepared
with anti-Xorc2 (lane 1) or control (lane 2)
antibodies were silver-stained. B and C,
anti-Xorc2 and mock immunoprecipitates
were processed for immunoblotting with
either anti-Xorc1 or anti-Xorc2 antibod-
ies, respectively.
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various constituent proteins during the cell cycle. For this
purpose, M phase and interphase egg extracts were radiola-
beled with 32P and subjected to immunoprecipitation with anti-
Xorc2 antibodies (Fig. 2A). Only Xorc1 and Xorc2 became de-
tectably phosphorylated under these experimental conditions.
The labeling of both proteins was stronger at M phase (Fig. 2A,
lane 1), but significant phosphorylation of both Xorc1 and
Xorc2 could also be detected in interphase extracts (lane 3).
Similar amounts of both Xorc1 and Xorc2 were immunoprecipi-
tated from M phase and interphase extracts under these con-
ditions (data not shown). The functional significance of the M
phase phosphorylation is not known, but it does correlate with
the dissociation of XORC from the condensed chromosomes at
M phase (10). Furthermore, recent studies with both human
and frog Mcm (mini-chromosome maintenance) replication pro-
teins have also revealed a similar correlation between protein
phosphorylation and chromatin association (reviewed in Ref.
2). Thus, it is possible that extensive phosphorylation of some
replication proteins serves to remove them from the chromatin
during M phase. Significantly, the interphase phosphorylation
of Xorc1 and Xorc2 was unaffected by 15 mM GST-p21N, a Cdk
(cyclin-dependent kinase) inhibitor that completely blocks both
Cdk2-cyclin E activity and DNA synthesis in egg extracts (data
not shown). By phosphoamino acid analysis, we found that the
M phase forms of Xorc1 and Xorc2 were phosphorylated on both
serine and threonine, whereas the interphase forms appeared
to contain mostly phosphoserine. In conclusion, Xorc1 and
Xorc2 appear to be the most heavily phosphorylated subunits of
XORC, and their phosphorylation increases greatly at M phase.
Cloning of the 81-kDa Xorc2-associated Protein—To isolate
enough of the Xorc2-containing complex for peptide sequenc-
ing, we carried out multiple large-scale immunoprecipitations.
From ;20 ml of egg extract, we obtained approximately 10 mg
of each Xorc2-associated protein. Our interest first centered on
p81, an 81-kDa polypeptide that migrates between Xorc1 and
Xorc2 (Fig. 1A, lane 1). The sequences of three tryptic peptides
from p81 were used to design degenerate oligonucleotides for
PCR. One combination of primers yielded a 1.6-kb PCR frag-
ment, which was used to screen a Xenopus oocyte cDNA library
(18, 26). Eighteen positive clones were isolated, and the largest
one, pC84-1A, was found to contain ;2300 nucleotide base
pairs and to encode a predicted protein of 81 kDa (Fig. 3).
We used the sequence of Xenopus p81 to search against
current data bases using the BLAST and PSI-BLAST programs
(31). p81 possesses no obvious structural motifs that might lend
a clue to its biochemical function, although it does have a
potential bipartite nuclear localization signal at residues 533–
546 (KKLLEMKETRRTKK). p81 was found to be highly ho-
mologous to several human expressed sequence tags of un-
known function (GenBankTM accession numbers of a few
examples are U50950, AA317247, and H94935). The homolo-
gous expressed sequence tags were derived from a variety of
tissues including retina, heart, colon, and brain. In addition,
p81 was found to be strongly homologous to several expressed
sequence tags from embryonic mice (e.g. GenBankTM accession
numbers AA073564 and W98988). We found no significant
sequence similarities between Xenopus p81 and any proteins
from Caenorhabditis elegans, Drosophila, or Arabidopsis. A
directed search with Xenopus p81 against the S. cerevisiae
genome yielded no significant sequence homologies with an E
value of ,0.01. A subthreshold score was detected between p81
and budding yeast Orc3 (GenBankTM Z73109; E value of 3.4
with the PSI-BLAST program). Three other budding yeast pro-
teins scored higher than Orc3 in this search. These include a
protein of unknown function (GenBankTM D50617), a putative
transcriptional regulatory protein (GenBankTM Z35827), and a
subunit of the proteasome (GenBankTM Z75169). Overall, p81
shares 21% identical residues with budding yeast Orc3. An
internal region of p81 (residues 215–406) is ;25% identical to
residues 201–400 of budding yeast Orc3. Thus, it is possible
that p81 represents a novel, highly diverged form of Orc3
present in higher eukaryotes.
Characterization of Xenopus p81—To characterize the func-
tional properties of p81, we first expressed p81 with a six-
histidine tag at its N terminus in baculovirus-infected Sf9
insect cells. Recombinant His6-p81 (Fig. 4A), which migrated as
an 84-kDa band on SDS gels due to the addition of the histidine
tag, was used to generate polyclonal antibodies in rabbits. The
anti-p81 antibodies, which reacted strongly with His6-p81, also
recognized an endogenous 81-kDa polypeptide in Xenopus egg
extracts (Fig. 4A), which migrated at the same position as
immunopurified p81 (data not shown).
Since p81 had been isolated originally by immunoprecipita-
FIG. 2. Phosphorylation of XORC constituents during the cell
cycle. A, M phase and interphase (I-phase) extracts were labeled with
[32P]orthophosphate and immunoprecipitated with either anti-Xorc2
(lanes 1 and 3) or control (lanes 2 and 4) antibodies. B, shown are the
results from the phosphoamino acid analysis of Xorc1 and Xorc2. S,
phosphoserine; T, phosphothreonine.
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tion with anti-Xorc2 antibodies, we asked whether the anti-p81
antibodies could be used to immunoprecipitate Xorc2 from egg
extracts. Co-immunoprecipitation experiments were performed
with anti-p81, anti-Xorc2, or control antibodies that had previ-
ously been coupled to protein A. After a 1-h incubation at 4 °C,
the beads were washed extensively and eluted with SDS, and
the SDS-eluted proteins were analyzed by immunoblotting
with either anti-Xorc2 (Fig. 4B) or anti-p81 (Fig. 4C) antibod-
ies. The results clearly demonstrate that Xorc2 could be effi-
ciently immunoprecipitated with anti-p81 antibodies and that
these antibodies could immunoblot the 81-kDa protein that had
been immunoprecipitated with anti-Xorc2 antibodies. p81 and
Xorc2 appeared to be tightly associated in the same complex
since these two proteins could still be co-immunoprecipitated
after washing in solutions containing 2 M NaCl or 1 M urea or in
radioimmune precipitation assay buffer containing 1% Nonidet
P-40 and 0.1% SDS (data not shown).
To characterize the expression of p81, we examined the lev-
els of p81 as well as those of Xorc2 in developmentally staged
Xenopus embryos. Embryos from a variety of stages, including
ones before and after the mid-blastula transition (stage 8.5),
were prepared and processed for immunoblotting with anti-p81
and anti-Xorc2 antibodies (Fig. 4D). The results indicate that
p81 and Xorc2 are present through at least stage 28 of devel-
opment (tail bud stage). Additionally, we found that p81 is
present in Xenopus tissue culture cells and could be co-immu-
noprecipitated with Xorc2 in these cells (data not shown). Thus,
p81 does not appear to be restricted to early embryonic cells
with a very rapid S phase.
Depletion of p81 from Egg Extracts—To assess the role of p81
in DNA replication, we depleted endogenous p81 from inter-
phase egg extracts by treatment with anti-p81 antibodies. Be-
cause of the high abundance of p81 in egg extracts (;5 ng/ml;
data not shown) and the relatively low affinity of the anti-p81
antibodies, we found it necessary to use three rounds of deple-
tion. After this procedure, we could no longer detect any p81 in
the depleted extracts relative to extracts that had been treated
with a control antibody (Fig. 5A, lanes 1 and 2). Significantly,
we also could not detect any Xorc2 protein in p81-depleted
extracts (Fig. 5B). Because Xorc2 could not be detected in
p81-depleted extracts, we asked if p81 could be found in ex-
tracts that had been depleted of Xorc2. Interphase extracts
were treated with anti-Xorc2 or control antibodies as described
previously (18). Essentially all of the Xorc2 was removed (Fig.
5C), and DNA replication was reduced to 5% of the control level
in this extract (data not shown). We then determined the con-
centration of p81 in this Xorc2-depleted extract. By immuno-
blotting, there was no detectable p81 protein in Xorc2-depleted
extracts (Fig. 5D). Collectively, these results indicate that
Xorc2 and p81 are associated quantitatively in the same
FIG. 3. Nucleotide and predicted
amino acid sequences of the p81
cDNA. The sequences corresponding to
the three tryptic fragments from immuno-
purified p81 are underlined.
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complex.
Next, we measured the abilities of the p81-depleted and
mock-depleted extracts to carry out the replication of exog-
enously added sperm chromatin. We performed a continuous
labeling in the presence of [a-32P]dCTP for 2 h at 23 °C and
assessed the extent of DNA synthesis by agarose gel electro-
phoresis (Fig. 5E, lanes 1 and 2). We observed that incorpora-
tion of 32P into chromosomal DNA was virtually abolished in
interphase extracts that had been depleted of p81. This inhibi-
tion of replication was not a consequence of the inability of the
extract to form intact nuclei around sperm chromatin, a re-
quirement for DNA replication in the Xenopus cell-free system,
since nuclear assembly occurred at similar rates in the p81-
depleted and control extracts (data not shown).
To rule out the possibility that the immunodepletion proce-
dure might irreversibly inactivate the extracts, we attempted
to restore the replicative capacity to the p81-depleted extracts.
Because recombinant p81 from Sf9 insect cells is completely
insoluble and because endogenous p81 is present in a multi-
protein complex in egg extracts, we did not attempt to rescue
the p81-depleted extracts with exogenously added, recombi-
nant p81. Instead, we asked whether chromatin that had been
preloaded with XORC in S phase cytosol (22) could be repli-
cated upon subsequent transfer to p81-depleted extracts. In-
deed, we found that loaded chromatin underwent replication at
an efficiency of ;80% in p81-depleted extracts relative to con-
trol depleted extracts (Fig. 5, E and F). The loaded chromatin
by itself did not undergo replication unless incubated in a
complete, membrane-containing extract (data not shown).
Taken together, these results indicate that removal of p81 and
its associated proteins (including Xorc2) from egg extracts com-
pletely abolishes the replication of chromosomal DNA. How-
ever, this defect can be bypassed if chromatin already contain-
ing XORC is added to the p81-depleted extract.
DISCUSSION
In this report, we have analyzed the composition of XORC
from Xenopus egg extracts. We have used highly specific anti-
bodies against Xorc2 to immunopurify a multiprotein complex
consisting of Xorc2 and up to five additional polypeptides.
Similar preparations of anti-Xorc2 antibodies, which recognize
a single 63-kDa protein in egg extracts by immunoblotting,
were used previously to immunodeplete Xorc2 and its associ-
ated proteins quantitatively from Xenopus egg extracts (18).
These Xorc2-depleted extracts are completely defective in chro-
mosomal DNA replication, indicating that the Xorc2-contain-
ing complex has an essential role in this process.
In addition to Xorc2 (p63), the immunoisolated complex con-
sists of Xorc1 (p115), p81, p78, p45, and p40. Although a pro-
tein with the same mobility as p78 can be immunoprecipitated
to some extent with control antibodies, the remaining five
polypeptides (p115/Xorc1, p81, p63/Xorc2, p45, and p40) bind
specifically to beads containing anti-Xorc2 antibodies. Among
the unidentified proteins, we first focused our attention on p81.
By cloning the cDNA encoding p81 and expressing recombinant
His6-p81, we were able to prepare antibodies that could immu-
nodeplete this protein from extracts of Xenopus eggs. Immu-
nodepletion with anti-p81 antibodies also resulted in the quan-
titative removal of Xorc2. Similarly, by immunodepleting with
anti-Xorc2 antibodies, we were able to completely remove p81
from egg extracts. These experiments establish that both p81
and Xorc2 are quantitatively associated in the same complex.
Furthermore, both p81 and Xorc2 appear to be tightly associ-
ated with this complex since both polypeptides can be co-im-
munoprecipitated with one another after washes in buffers
containing 2 M NaCl, 1 M urea, or relatively harsh detergents
(e.g. 1% CHAPS or a mixture of 1% Nonidet P-40 and 0.1%
SDS). Significantly, p81-depleted extracts are also completely
defective in chromosomal DNA replication.
In previous studies, two groups have also observed multiple
proteins within putative XORC. Rowles et al. (20) isolated a
complex of up to nine polypeptides using anti-Xorc1 antibodies
to follow its purification through a number of chromatographic
steps. These polypeptides include p168, p115/Xorc1, p110, p86,
p74, p63/Xorc2, p50, p46, and p40. Of these, p110 and p50 were
FIG. 4. Characterization of Xenopus
p81. A, recombinant histidine-tagged p81
was stained with Coomassie Blue (3 mg of
protein; lane 1) or immunoblotted with
anti-p81 antibodies (50 ng of protein; lane
2). Interphase egg extract was immuno-
blotted with anti-p81 antibodies (lane 3).
B and C, Xorc2 and p81 were co-immuno-
precipitated. Interphase extracts (50 ml)
were treated with control (lane 1), anti-
Xorc2 (lane 2), or anti-p81 (lane 3) anti-
bodies bound to protein A beads. The
washed beads were processed for immu-
noblotting with either anti-Xorc2 (B) or
anti-p81 (C) antibodies. D, p81 and Xorc2
were detected during Xenopus develop-
ment. Extracts from Xenopus eggs (cyto-
static factor (CSF) or staged (Stg.) em-
bryos were immunoprecipitated with
anti-p81 antibodies and immunoblotted
with either anti-p81 (upper panel) or anti-
Xorc2 (lower panel) antibodies.
Xenopus Origin Recognition Complex 24895
relatively minor components. Furthermore, p86 did not cofrac-
tionate precisely with p115/Xorc1 and p63/Xorc2 during MonoS
chromatography. In other studies with anti-Xorc1 antibodies,
Romanowski et al. (30) were able to immunoprecipitate a com-
plex of five proteins, including Xorc1, Xorc2, a protein that
migrated between Xorc1 and Xorc2 on SDS gels, and two pro-
teins that migrated between Xorc2 and a 45-kDa marker pro-
tein. Although the composition of XORC could not be estab-
lished conclusively in these two studies, it appears that this
complex consists of five to nine polypeptides, including at least
one unknown protein with a molecular mass of 74–85 kDa that
migrates between Xorc1 and Xorc2 on SDS gels. A generally
similar polypeptide composition has been observed for ORC
from Drosophila (17). Based upon our studies, it appears that
the p81 described in this paper is also present in the XORC
preparations of both Rowles et al. (20) and Romanowski et al.
(30).
Interestingly, although p81 possesses close homologs of pre-
viously undetermined function in humans and mice, there ap-
pears not to be an obvious homolog of this protein in budding
yeast (E , 0.01). This conclusion is based on a search of the S.
cerevisiae genome with the BLAST and PSI-BLAST programs.
Among the budding yeast ORC subunits, p81 scored highest
with Orc3, raising the possibility that p81 might represent a
highly diverged form of Orc3 found in higher eukaryotes. Al-
though homologs of S. cerevisiae Orc1, Orc2, Orc4, and Orc5
have been readily identified in metazoans (2), homologs of Orc3
and Orc6 have not been described thus far in other organisms.
This might suggest that these particular subunits have not
been conserved as stringently during evolution.
In principle, p81 could be an integral component of XORC
that is required for initiation of replication on DNA templates,
and indeed, this is the simplest and most obvious possibility.
The limited similarity between p81 and budding yeast Orc3
would be consistent with this interpretation. The lack of close
similarity between p81 and the budding yeast ORC subunits
might be explained by a difference between origins of replica-
tion in higher eukaryotes and yeast. Alternatively, it is for-
mally possible that p81 could represent either a tightly associ-
ated regulator of XORC or a factor that collaborates with XORC
in the replication process. The functional reconstitution of
XORC with recombinant proteins will be necessary to elucidate
the precise function of p81 in the control of DNA replication.
Acknowledgments—We thank Judith Campbell, Ray Deshaies, and
members of the Dunphy laboratory for valuable comments during the
course of this work. We are indebted to Wenying Shou for the generous
gift of developmentally staged Xenopus embryos and to the California
Institute of Technology Protein/Peptide Micro Analytical Laboratory for
FIG. 5. Immunodepletion of p81
from Xenopus egg extracts abolishes
DNA replication. A and B, immunopre-
cipitation with anti-p81 antibodies quan-
titatively removes both p81 and Xorc2
from egg extracts. Interphase egg extract
(50 ml) was treated with either control
(lane 1) or anti-p81 (lane 2) antibodies
bound to protein A beads. Following re-
moval of the beads by centrifugation, the
supernatants were subjected to immuno-
blotting with either anti-p81 (A) or anti-
Xorc2 (B) antibodies. C and D, immuno-
precipitation with anti-Xorc2 antibodies
quantitatively removes both Xorc2 and
p81. Interphase egg extracts were treated
with either anti-Xorc2 (lane 1) or control
(lane 2) antibodies bound to protein A
beads. Following removal of the beads,
the supernatants were immunoblotted
with either anti-Xorc2 (C) or anti-p81 (D)
antibodies. In this experiment, DNA rep-
lication in the Xorc2-depleted extract was
reduced to 5% of the control value. E and
F, measurement of DNA replication in
p81-depleted extracts. Control depleted
(mock; lanes 1 and 3) or p81-depleted
(lanes 2 and 4) extracts were supple-
mented with [a-32P]dCTP and sperm
chromatin to measure DNA replication.
The same extracts were also assayed for
their ability to replicate chromatin that
had been preloaded with XORC by incu-
bation in S phase cytosol (lanes 3 and 4). F
is a quantitation of E.
Xenopus Origin Recognition Complex24896
protein sequencing. We also thank Julian Blow and Alison Rowles for
providing anti-Xorc1 antibodies.
REFERENCES
1. Stillman, B. (1996) Science 274, 1659–1664
2. Dutta, A., and Bell, S. P. (1997) Ann. Rev. Cell Dev. Biol. 13, 293–332
3. Diffley, J. F., and Cocker, J. H. (1992) Nature 357, 169–172
4. Diffley, J. F., Cocker, J. H., Dowell, S. J., and Rowley, A. (1994) Cell 78,
303–316
5. Aparicio, O. M., Weinstein, D. M., and Bell, S. P. (1997) Cell 91, 59–69
6. Donovan, S., Harwood, J., Drury, L. S., and Diffley, J. F. (1997) Proc. Natl.
Acad. Sci. U. S. A. 94, 5611–5616
7. Liang, C., and Stillman, B. (1997) Genes Dev. 11, 3375–3386
8. Tanaka, T., Knapp, D., and Nasmyth, K. (1997) Cell 90, 649–660
9. Cocker, J. H., Piatti, S., Santocanale, C., Nasmyth, K., and Diffley, J. F. X.
(1996) Nature 379, 180–182
10. Coleman, T. R., Carpenter, P. B., and Dunphy, W. G. (1996) Cell 87, 53–63
11. Jackson, P. K., Chevalier, S., Philippe, M., and Kirschner, M. W. (1995) J. Cell
Biol. 130, 755–769
12. Yan, H., and Newport, J. (1995) J. Cell Biol. 129, 1–15
13. Lei, M., Kawasaki, Y., Young, M. R., Kihara, M., Sugino, A., and Tye, B. K.
(1997) Genes Dev. 11, 3365–3374
14. Sato, N., Arai, K.-I., and Masai, H. (1997) EMBO J. 16, 4340–4351
15. Bell, S. P., Mitchell, J., Leber, J., Kobayashi, R., and Stillman, B. (1995) Cell
83, 563–568
16. Gavin, K. A., Hidaka, M., and Stillman, B. (1995) Science 270, 1667–1671
17. Gossen, M., Pak, D. T. S., Hansen, S. K., Acharya, J. K., and Botchan, M. R.
(1995) Science 270, 1674–1677
18. Carpenter, P. B., Mueller, P. R., and Dunphy, W. G. (1996) Nature 379,
357–360
19. Leatherwood, J., Lopez-Girona, A., and Russell, P. (1996) Nature 379, 360–363
20. Rowles, A., Chong, J. P., Brown, L., Howell, M., Evan, G. I., and Blow, J. J.
(1996) Cell 87, 287–296
21. Murray, A. W. (1991) Methods Cell Biol. 36, 581–605
22. Smythe, C., and Newport, J. W. (1991) Methods Cell Biol. 35, 449–468
23. Shou, W., and Dunphy, W. G. (1996) Mol. Biol. Cell 7, 457–469
24. Schneider, C., Newman, R. A., Sutherland, D. R., Asser, U., and Greaves, M. F.
(1982) J. Biol. Chem. 257, 10766–10769
25. Boyle, W. J., van der Geer, P., and Hunter, T. (1991) Methods Enzymol. 210,
110–149
26. Mueller, P. R., Coleman, T. R., and Dunphy, W. G. (1995) Mol. Biol. Cell 6,
119–134
27. Kozak, M. (1986) Cell 44, 283–292
28. Kumagai, A., and Dunphy, W. G. (1995) Mol. Biol. Cell 6, 199–213
29. Chen, J., Jackson, P. K., Kirschner, M. W., and Dutta, A. (1995) Nature 374,
386–388
30. Romanowski, P., Madine, M., Rowles, A., Blow, J. J., and Laskey, R. A. (1996)
Curr. Biol. 6, 1416–1425
31. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W.,
and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389–3402
Xenopus Origin Recognition Complex 24897
